We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Shutterstock
Cohen & Steers' (CNS) February AUM Down on Unfavorable Markets
Cohen & Steers (CNS - Free Report) reported preliminary assets under management (AUM) of $98.9 billion as of Feb 28, 2022, which reflects a decline of 3.1% from the prior-month level. Market depreciation of $3.5 billion and distributions of $197 million were partially offset by net inflows of $479 million.
CNS recorded total institutional accounts of $39.7 billion at the end of February, down 3.5% from the January-end level. Of the total institutional accounts, advisory accounts were $23.4 billion, while the rest were sub-advisory.
Cohen & Steers recorded $46.8 billion in open-end funds, down 3.4% from a month ago. Closed-end funds were $12.4 billion, down 0.7% from January 2022.
The company’s diverse product offerings, global reach and investment strategies are expected to keep supporting financials. Its solid AUM balance will likely keep aiding the top line. However, elevated expenses are expected to impede bottom-line growth to some extent.
Over the past six months, shares of CNS have lost 12.3% compared with a 15% decline recorded by the industry.
Image Source: Zacks Investment Research
Among other asset managers, Invesco (IVZ - Free Report) and T. Rowe Price (TROW - Free Report) are expected to release preliminary AUM results for February in the coming days.
Over the past six months, shares of IVZ have lost 21.2%, while the TROW stock has lost 37.7%.